190 related articles for article (PubMed ID: 18628498)
1. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Zhao WH; Hu ZQ; Shimamura T
J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
3. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
5. PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability.
Montaner M; Lopez-Argüello S; Oliver A; Moya B
Microbiol Spectr; 2023 Feb; 11(1):e0303822. PubMed ID: 36475840
[TBL] [Abstract][Full Text] [Related]
6. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
10. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa.
Manoharan A; Chatterjee S; Mathai D;
Indian J Med Microbiol; 2010; 28(3):241-4. PubMed ID: 20644314
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
[TBL] [Abstract][Full Text] [Related]
13. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.
Kazmierczak KM; Rabine S; Hackel M; McLaughlin RE; Biedenbach DJ; Bouchillon SK; Sahm DF; Bradford PA
Antimicrob Agents Chemother; 2016 Feb; 60(2):1067-78. PubMed ID: 26643349
[TBL] [Abstract][Full Text] [Related]
14. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
[TBL] [Abstract][Full Text] [Related]
15. Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates.
Li Y; Zhu Y; Zhou W; Chen Z; Moran RA; Ke H; Feng Y; van Schaik W; Shen H; Ji J; Ruan Z; Hua X; Yu Y
Clin Microbiol Infect; 2022 Jun; 28(6):880.e1-880.e8. PubMed ID: 34826621
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
17. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.
Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289035
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.
Yano H; Kuga A; Okamoto R; Kitasato H; Kobayashi T; Inoue M
Antimicrob Agents Chemother; 2001 May; 45(5):1343-8. PubMed ID: 11302793
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
[TBL] [Abstract][Full Text] [Related]
20. beta-Lactam susceptibility patterns and investigation of cephalosporin hydrolysing beta-lactamases of Gram-negative extraintestinal clinical isolates.
Gál Z; Szabó D; Kovács P; Hernádi F; Tóth-Martinez B; Rozgonyi F
Int J Antimicrob Agents; 2000 Dec; 16(4):395-400. PubMed ID: 11118847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
